Henan Taloph Pharmaceutical Stock Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 8.32% vs -34.87% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -11.54% vs -87.32% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "350.20",
          "val2": "323.30",
          "chgp": "8.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.60",
          "val2": "34.50",
          "chgp": "-60.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.00",
          "val2": "14.40",
          "chgp": "-2.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.50",
          "val2": "0.10",
          "chgp": "3,400.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.30",
          "val2": "2.60",
          "chgp": "-11.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "38.80%",
          "val2": "48.60%",
          "chgp": "-0.98%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -9.56% vs -6.26% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 23.18% vs 19.42% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,750.50",
          "val2": "1,935.60",
          "chgp": "-9.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "199.50",
          "val2": "146.70",
          "chgp": "35.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "60.10",
          "val2": "61.20",
          "chgp": "-1.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.40",
          "val2": "7.90",
          "chgp": "-82.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "65.90",
          "val2": "53.50",
          "chgp": "23.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "72.20%",
          "val2": "38.00%",
          "chgp": "3.42%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

350.20

323.30

8.32%

Operating Profit (PBDIT) excl Other Income

13.60

34.50

-60.58%

Interest

14.00

14.40

-2.78%

Exceptional Items

3.50

0.10

3,400.00%

Consolidate Net Profit

2.30

2.60

-11.54%

Operating Profit Margin (Excl OI)

38.80%

48.60%

-0.98%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 8.32% vs -34.87% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -11.54% vs -87.32% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,750.50

1,935.60

-9.56%

Operating Profit (PBDIT) excl Other Income

199.50

146.70

35.99%

Interest

60.10

61.20

-1.80%

Exceptional Items

1.40

7.90

-82.28%

Consolidate Net Profit

65.90

53.50

23.18%

Operating Profit Margin (Excl OI)

72.20%

38.00%

3.42%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -9.56% vs -6.26% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 23.18% vs 19.42% in Dec 2024

All Annual Results